WO2002005847A1 - METHODE DE KUBOUCHI D'INJECTION INTRAMUSCULAIRE D'UN MELANGE DE MEDICAMENT AVEC LE SANG DU PATIENT ET SUBSTANCES DE KUBOUCHI AINSI PRODUITES - Google Patents

METHODE DE KUBOUCHI D'INJECTION INTRAMUSCULAIRE D'UN MELANGE DE MEDICAMENT AVEC LE SANG DU PATIENT ET SUBSTANCES DE KUBOUCHI AINSI PRODUITES Download PDF

Info

Publication number
WO2002005847A1
WO2002005847A1 PCT/JP2000/007426 JP0007426W WO0205847A1 WO 2002005847 A1 WO2002005847 A1 WO 2002005847A1 JP 0007426 W JP0007426 W JP 0007426W WO 0205847 A1 WO0205847 A1 WO 0205847A1
Authority
WO
WIPO (PCT)
Prior art keywords
apos
kubouchi
blood
acth
patient
Prior art date
Application number
PCT/JP2000/007426
Other languages
English (en)
Japanese (ja)
Inventor
Sadayuki Kubouchi
Original Assignee
Sadayuki Kubouchi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sadayuki Kubouchi filed Critical Sadayuki Kubouchi
Publication of WO2002005847A1 publication Critical patent/WO2002005847A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Definitions

  • the pituitary gland which cannot be imagined from individual drugs, is mixed with an existing drug and a patient's blood by intramuscular injection (usually called the Kubo method).
  • a strong stimulus causes the hormones ACTH, TSH, FSH, LH, and GH (especially ACTH) to be secreted in large quantities almost simultaneously at the same time, thereby leading to allergic rhinitis and hay fever.
  • ACTH hormones
  • TSH TSH
  • FSH farnesoheptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptepteptept
  • the conventional methods for allergic rhinitis and hay fever are limited to desensitization therapy and symptomatic treatment with steroids. It has many side effects. It is a horny agent for rejuvenation, but it is temporary and may cause side effects. For palsy, antacids, mucosal protective materials, and disinfectants are mainly used. However, it is intractable and there are many recurrences-Diabetes is insulin and oral medicine, but the dose gradually increases-
  • the substance in Kubo produced by the method inside, strongly stimulates the pituitary gland and secretes the hormones ACTH, TSH, FSH, LH, GH (especially ACTH) in large quantities almost simultaneously, and in a well-balanced manner.
  • the subjective symptoms of the above diseases can be cured.
  • the interval is two or three times a week, but no side effects occur when injected daily or twice at a time. From the 15th time, once every few weeks is sufficient.
  • a particularly interesting phenomenon is that men tend to "wake up" often from the 6th or 7th time, and the penis remains rigid for 10 to 30 seconds (depending on age) after ejaculation.
  • vaginal discharge increases, sexual sensation increases, and sexual desire seems to increase.
  • Four women have been scholared. The amount of menstruation increases and menstrual pain often disappears.
  • the vertical axis shows the amount of secretion.
  • the horizontal axis indicates the number of injections.
  • the “0” on the horizontal axis indicates the volume before injection. 3.
  • the missing part of the test value indicates that the amount of blood collected was insufficient but the injection was performed but the test was not performed.
  • the test was outsourced to a specialized company (Tokyo Clinical Laboratory Center).
  • the blood collection time was more than 5 PM.
  • the format of the reported harm changed from January due to the laboratories.
  • the amount of ACTH is a multiple when compared to the pre-injection amount.
  • Fig. 1 ⁇ , ⁇ . 30-year-old woman, had allergic rhinitis and stomach ulcer, but both were almost completely cured by 16 injections.
  • Fig. 3. IY37 ⁇ . Women. She had been visiting the hospital from Sendai City for nervous colitis and allergic rhinitis. (Sister of KY and KY's allergic rhinitis, which became better, so I recommend her. I was injected twice a time. (Described later) Stopped due to family circumstances. The headache during menstruation disappeared. Fig. 4. YK 76-year-old woman, injection for gastric cancer and rejuvenation. After the ninth injection, a cure of stomach ache was confirmed at T University Hospital. In addition, my friends began to be beheaded if they had rejuvenated. Fig. 5. TM 62-year-old woman. 14 injections by November of last year, eyes became itchy in February this year, and one injection in April and almost another one in April, almost cured! SK 74 years old. Male: Injection for the purpose of rejuvenation. Potentials have improved, physical strength.
  • K. 1. A 33-year-old man. Atopic dermatitis from childhood. See below Oral administration of steroids for the purpose of preventing deterioration until the 6th time. Discontinuation. Since then, it has gradually improved, but Fig. 11 to 15 are hormone-specific summaries.
  • LH, FSH, and TSH of YT show remarkable amounts, respectively, and especially, ACTH and TSH have almost extinction curves. These are used to elucidate problems such as diabetes and fertility. Presumed to be useful It is a confession that sexual intercourse, which had been impossible for several years before the injection, became possible from around the 7th.
  • the body of the armor was also of the allergic nature, and the tip of the iceberg was ⁇ .
  • the tip of the iceberg was ⁇ .
  • a 28-year-old was cured with 13 injections. No recurrence occurred 12 years later.
  • YM and YK Gastric carcinoma has been cured. (However, these three cases are not willing to discuss all of gastric acne, but I am willing to go away even if I did not hit it.)

Abstract

L'invention concerne une nouvelle méthode thérapeutique de sécrétion simultanée d'une grande quantité d'hormones pituitaires (en particulier, ACTH) d'une manière bien équilibrée dans le corps humain par une méthode unique de kubouchi consistant à mélanger un constituant médicamenteux, lequel a été employé usuellement, avec le sang du patient et à injecter par voie intramusculaire le mélange ainsi obtenu. Par l'utilisation de cette méthode, la rhinite allergique et la pollinose peuvent être presque complètement guéries et un effet rajeunissant remarquable est obtenu sans présenter aucun effet secondaire. De plus, des effets remarquables peuvent également être obtenus ainsi sur l'ulcère gastrique, le diabète ainsi que plusieurs maladies chroniques, dans certains cas. Les substances de kubouchi produites par le procédé précité peuvent être utilisées à diverses fins dans le domaine de la médecine, notamment dans le traitement des maladies ci-dessus décrites.
PCT/JP2000/007426 2000-07-19 2000-10-24 METHODE DE KUBOUCHI D'INJECTION INTRAMUSCULAIRE D'UN MELANGE DE MEDICAMENT AVEC LE SANG DU PATIENT ET SUBSTANCES DE KUBOUCHI AINSI PRODUITES WO2002005847A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000/25163620000719 2000-07-19
JP2000251636 2000-07-19

Publications (1)

Publication Number Publication Date
WO2002005847A1 true WO2002005847A1 (fr) 2002-01-24

Family

ID=18741004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2000/007426 WO2002005847A1 (fr) 2000-07-19 2000-10-24 METHODE DE KUBOUCHI D'INJECTION INTRAMUSCULAIRE D'UN MELANGE DE MEDICAMENT AVEC LE SANG DU PATIENT ET SUBSTANCES DE KUBOUCHI AINSI PRODUITES

Country Status (1)

Country Link
WO (1) WO2002005847A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126401A (ja) * 2003-10-21 2005-05-19 L'oreal Sa カチオン性ポリ（ビニルラクタム）及び少なくとも一つのｃ１０〜ｃ１４脂肪アルコールを含むケラチン繊維の酸化染色組成物、酸化染色方法及び装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135918A (en) * 1988-03-21 1992-08-04 Broncorp Method for decreasing reaginic antibody levels
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135918A (en) * 1988-03-21 1992-08-04 Broncorp Method for decreasing reaginic antibody levels
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KAMATA TOMOSUKE ET AL.: "Solcoseryl no I nenmaku ketsuryuu zouka sayou ni kansuru jikken-teki kentou", RINSHOU TO KISO, vol. 17, no. 12, 1983, pages 4077 - 4080, XP002936073 *
KODAMA MITSUO ET AL.: "Vitamin C infusion treatment enhances cortisol production of the adrenal via the pituitary ACTH route", IN VIVO, vol. 8, no. 6, 1994, pages 1079 - 1086, XP002936075 *
MARKIEWICZ WALTER ET AL.: "The acute effect of minocycline on the pericardium, experimental and clinical findings", CHEST, vol. 113, no. 4, 1998, pages 861 - 866, XP002936072 *
NAMIMATSU AKIO ET AL.: "Regulatory effect of neurotropin on nasal mucosalhypersensitivity in guinea pig caused by SART (intermittent exposure to cold) stress", JPN. J. PHARMACOL., vol. 59, no. 3, 1992, pages 371 - 377, XP002936074 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005126401A (ja) * 2003-10-21 2005-05-19 L'oreal Sa カチオン性ポリ（ビニルラクタム）及び少なくとも一つのｃ１０〜ｃ１４脂肪アルコールを含むケラチン繊維の酸化染色組成物、酸化染色方法及び装置

Similar Documents

Publication Publication Date Title
Summers Methods of cervical ripening and labor induction
US8178498B1 (en) Medicament and method of treating an organism with medicaments
JP2002053485A (ja) アレルギー性疾患用医薬組成物
Otsuka et al. Refractory oral ulcers in eosinophilic granulomatosis with polyangiitis
CN1422651A (zh) 治疗妇产科疾病的药物及其制备方法
WO2002005847A1 (fr) METHODE DE KUBOUCHI D'INJECTION INTRAMUSCULAIRE D'UN MELANGE DE MEDICAMENT AVEC LE SANG DU PATIENT ET SUBSTANCES DE KUBOUCHI AINSI PRODUITES
Loeb et al. Systematic approach to diagnosis and management of biphasic insulin allergy with local anti-inflammatory agents
TAUBENHAUS et al. Clinical and histological observations on a case of scleroderma treated with cortisone
JPH08198768A (ja) 糖尿病治療剤
Oravec et al. Management of diabetes insipidus in pregnancy.
Arita et al. Treatment of elderly acromegalics
Dooley et al. Norethandrolone in cystic fibrosis of thepancreas
JP2002537359A (ja) 医薬品としての使用のため若しくは医薬品の製造のための水中油型エマルション
Ray et al. Intralesional MMR versus intralesional bleomycin in the treatment of digital warts: A randomized comparative study and review of the literature
Palombaro et al. Angioedema associated with droperidol administration
CN111991372B (zh) 医用皮肤修护贴在制备治疗皮炎药物中的应用
PASCHER et al. Erythrodermic Psoriasis in Children: A Report of Two Cases
CN105902792A (zh) 一种治疗支气管炎和哮喘的中药
Qureshi et al. New-Onset Insulin Allergy After COVID-19 Infection in an Insulin-Dependent Type-2 Diabetic Patient: A Rare Complication
Lurie Verrucae vulgares (palmar and plantar): treatment by intramuscular injections of bismuth salicylate
CN101138586A (zh) 核黄青黛口腔溃疡贴片
CN105770817A (zh) 一种益气活血除湿解毒皮肤病异病同治中药组合物配方
CN106109610A (zh) 一种治疗青春痘的中草药擦剂
LANGLEY et al. Aureomycin in epidemic parotitis
CN105902735A (zh) 一种治疗哮喘性支气管炎的中药组方

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
WA Withdrawal of international application
ENP Entry into the national phase

Ref document number: 20030940

Country of ref document: UZ

Kind code of ref document: A